Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination With Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease

NCT05643638 is registered in ClinicalTrials.gov with Cynata Therapeutics Limited as lead sponsor.

NCT NCT05643638
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05643638 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-Controlled Phase II Study to Investigate the Efficacy and Safety of CYP-001 in Combination With Corticosteroids vs Corticosteroids Alone for the Treatment of High-Risk Acute Graft Versus Host Disease
Lead sponsor
Cynata Therapeutics Limited
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 4, 2024
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease, acute